Carmignac Gestion’s BioNTech BNTX Stock Holding History

Carmignac Gestion’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$7.45M	Sell	79,875 -32,836	-29%	-$3.09M	0.1%	62
2026 Q1	$9.96M	Sell	112,711 -31,376	-22%	-$3.22M	0.15%	57
2025 Q4	$13.7M	Buy	144,087 +37,538	+35%	+$3.78M	0.19%	52
2025 Q3	$10.5M	Sell	106,549 -69,802	-40%	-$7.46M	0.16%	61
2025 Q2	$18.8M	Sell	176,351 -9,526	-5%	-$962K	0.29%	46
2025 Q1	$17M	Sell	185,877 -36,218	-16%	-$4.05M	0.28%	51
2024 Q4	$25.3M	Buy	222,095 +34,425	+18%	+$3.93M	0.4%	41
2024 Q3	$22.3M	Buy	187,670 +94,348	+101%	+$8.67M	0.37%	44
2024 Q2	$7.5M	Buy	+93,322	New	+$8.53M	0.13%	65

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Carmignac Gestion's BNTX Position: Q2 2026 in Review

Carmignac Gestion reduced its BioNTech (BNTX) stake by 29% in Q2 2026, selling an estimated $3.09M and leaving 79,875 shares worth $7.45M. The position accounts for 0.1% of the portfolio, ranked #62.

Carmignac Gestion first reported a position in BNTX in Q2 2024 and has held it in 9 quarters since. The position peaked at $25.3M in Q4 2024. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Carmignac Gestion held 79,875 shares of BioNTech worth $7.45M as of Q2 2026.
Carmignac Gestion sold 32,836 BioNTech shares in Q2 2026, an estimated $3.09M.
BioNTech made up 0.1% of Carmignac Gestion's portfolio in Q2 2026, its #62 holding.
Carmignac Gestion first reported a position in BioNTech in Q2 2024 and has held it in 9 quarters since.
Carmignac Gestion's BioNTech position peaked at $25.3M in Q4 2024.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Carmignac Gestion's 13F filing for Q2 2026, filed 13 Aug 2026.